Farmacie pro praxi. 2023;19(2):104-106
D-mannose in preventing recurrent urinary tract infections
- Urologická klinika LF UP a FN Olomouc
Urinary tract infections (UTIs) are frequent diseases, particularly in women. Acute simple cystitis poses no serious medical problem. However, a recurrent UTI, defined as the occurrence of two UTIs in six months, or three UTIs per year, decreases the quality of life of patients and leads to repeated antibiotic use. Daily routine measures and long-term prophylaxis with low-dose antibiotics or their targeted use in at-risk situations, e. g., prior to sexual intercourse or during hormonal changes, are recommended as methods of preventing recurrent UTIs. With long-term antibiotic use, patients may experience unpleasant adverse effects of this treatment and, what is more, the risk of growing bacterial resistance is increased. For this reason, the use of non-antimicrobial drugs is currently recommended. These methods of preventing recurrent UTIs also include the use of D-mannose.
Keywords: D-mannose, lower urinary tract infection, cystitis, recurrent urinary tract infection, non-antibiotic prophylaxis.
Published: June 7, 2023 Show citation
References
- European Association of Urology (EAU) Guidelines on Urological infection. 2022, uroweb.org.
- Hickling DR, Nitti VW. Management of reccurrent urinary tract infection in healthy adult women. Rev Urol. 2013;15(2):41-48.
Go to PubMed... - Nickel JC. Practical management of recurrent urinary tract infection in premanopausal women. Rev Urol. 2005;7:11-17. Go to PubMed...
- Gupta K,Stamm WE. Pathogenesis and management of recurrent urinary tract infection in women. World J R Urol. 1999;17:415-420.
Go to original source... Go to PubMed... - Alton G, Hasilik M, Niehues R, et al. Direct utilization of mannose for mammalian glycoprotein biosynthesis. Glycobiology. 2001;8:285-295. Go to original source... Go to PubMed...
- Hu X, Shi Y, Zhang P, et al. D mannose properties, production and applicantions. An overview. Compr Rec Food Sci Food Saf. 2016:15:773-785. Go to original source... Go to PubMed...
- Bouckaert J, Berglund J, Schembri M, et al. Receptor binding studies disclose a novel class od high affinity inhibitor sof Escherichia coli film adhesin, Mol Microbiol. 2005;55:441-455. Go to original source... Go to PubMed...
- Jones CH, Pinkner JS, Roth R, et al. FimH adhezin of type 1 pili is assembler into a fibrilar tip structure in Enterobariaceae. Proct Nati Acad Sci USA. 1995:92:2081-5. Go to original source... Go to PubMed...
- Aidelberg G, Towbin BD, Rothschild D, et al. Hierarchy of non-glucose sugars in escherichia coli. BMC syst Biol. 2014;8:133. Go to original source... Go to PubMed...
- Sarshar M, Behzadi P, Ambrosi C, et al. FimH nd antiadhesive therapeutics: A disaring strategy against uropatogens. Antibiotics (Basel). 2020;9:397. Go to original source... Go to PubMed...
- Lenger S, Bradley MS, Thomas DA, et al. D-mannose vs. other agents for recurrent urinary tract infection prevention in adult women: a systematic review and meta-analysis. Am J Obstet Gynecol. 2020;223(2):265-213. Go to original source... Go to PubMed...
- Ala-Jaakola R, Laitila A, Ouwehand AC, et al. Role of D-mannose in urinary tract infections - a narrative review. Nutr J. 2022;21:18. Go to original source... Go to PubMed...
- Kranjčec B, Papeš D, Altarac S, et al. D-mannose powder for prophylaxis of reccurent urinary tract infection in women: a randomized clinical trial. World J Urol. 2014;32(1):79-84. Go to original source... Go to PubMed...
- Porru D, Pirmigiani A, Tinelli C et al. Oral D-mannose in recurrent urinary tract infections in women: a pilot study. Journal of Clinical Urology. 2014;7(3):208-213. Go to original source...
- Domenici L, Monti M, Bracchi C, et al. D-mannose: a promising support for acute urinary tract infections in women. A pilot study. Eur Rev Med Pharmacol Sci. 2016;20(13):2920-2925. Go to PubMed...